Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Perry

Showing results (81-90 of 140) with videos related to

Pageof 14
Sort By:
Cancer|September 15, 1982
T-cell lymphoma occurring in the oropharynxD S Karcher, D J Perry, M A Hurwitz, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 10, 1997
Recurrent venous thromboembolic disease and factor XI concentrate in a patient with severe factor XI deficiency, chronic myelomonocytic leukaemia, factor V Leiden and heterozygous plasminogen deficiencyG Evans, K J Pasi, A Mehta, et al.
Hemoglobin|January 1, 1995
Compound heterozygosity for two beta chain variants: Hb S [beta 6(A3)Glu-->Val] and the high affinity variant Hb San Diego [beta 109(G11)Val-->Met]D Williamson, D J Perry, K Brown, et al.
FEBS Letters|August 28, 1989
Antithrombin Cambridge, 384 Ala to Pro: a new variant identified using the polymerase chain reactionD J Perry, P L Harper, S Fairham, et al.
The Orthopedic Clinics of North America|January 1, 1995
Gunshot wounds to the kneeD J Perry, D P Sanders, C D Nyirenda, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 7, 2006
Severe factor X deficiency due to a homozygous mutation (Cys364Arg) that disrupts a disulphide bond in the catalytic domainT Todd, D J Perry, E Hayman, et al.
Journal of Molecular Biology|February 28, 1997
Mapping sequence specific DNA-protein interactions: a versatile, quantitative method and its application to transcription factor XF1B Luo, D J Perry, L Zhang, et al.
European Journal of Haematology|April 16, 2003
Markers of platelet activation, thrombin generation and fibrinolysis in women with sickle cell disease: effects of differing forms of hormonal contraceptionW C Yoong, S M Tuck, K J Pasi, et al.
British Journal of Haematology|November 23, 2006
Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety AgencyT P Baglin, D Cousins, D M Keeling, et al.
American Journal of Hematology|November 1, 1995
Two antithrombin mutations in a compound heterozygote: Met20Thr and Tyr166CysD J Perry, M E Daly, B T Colvin, et al.
Pageof 14

Showing results (81-90 of 140) with videos related to

Sort By:
Pageof 14
Cancer|September 15, 1982
T-cell lymphoma occurring in the oropharynxD S Karcher, D J Perry, M A Hurwitz, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 10, 1997
Recurrent venous thromboembolic disease and factor XI concentrate in a patient with severe factor XI deficiency, chronic myelomonocytic leukaemia, factor V Leiden and heterozygous plasminogen deficiencyG Evans, K J Pasi, A Mehta, et al.
Hemoglobin|January 1, 1995
Compound heterozygosity for two beta chain variants: Hb S [beta 6(A3)Glu-->Val] and the high affinity variant Hb San Diego [beta 109(G11)Val-->Met]D Williamson, D J Perry, K Brown, et al.
FEBS Letters|August 28, 1989
Antithrombin Cambridge, 384 Ala to Pro: a new variant identified using the polymerase chain reactionD J Perry, P L Harper, S Fairham, et al.
The Orthopedic Clinics of North America|January 1, 1995
Gunshot wounds to the kneeD J Perry, D P Sanders, C D Nyirenda, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 7, 2006
Severe factor X deficiency due to a homozygous mutation (Cys364Arg) that disrupts a disulphide bond in the catalytic domainT Todd, D J Perry, E Hayman, et al.
Journal of Molecular Biology|February 28, 1997
Mapping sequence specific DNA-protein interactions: a versatile, quantitative method and its application to transcription factor XF1B Luo, D J Perry, L Zhang, et al.
European Journal of Haematology|April 16, 2003
Markers of platelet activation, thrombin generation and fibrinolysis in women with sickle cell disease: effects of differing forms of hormonal contraceptionW C Yoong, S M Tuck, K J Pasi, et al.
British Journal of Haematology|November 23, 2006
Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety AgencyT P Baglin, D Cousins, D M Keeling, et al.
American Journal of Hematology|November 1, 1995
Two antithrombin mutations in a compound heterozygote: Met20Thr and Tyr166CysD J Perry, M E Daly, B T Colvin, et al.
Pageof 14